SBI Securities’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$516 Buy
311
+6
+2% +$10 ﹤0.01% 3105
2026
Q2
$622 Buy
305
+5
+2% +$9 ﹤0.01% 2967
2026
Q1
$537 Buy
300
+250
+500% +$530 ﹤0.01% 2871
2025
Q4
$112 Buy
+50
New +$131 ﹤0.01% 3372
2025
Q3
– Sell
-201
Closed -$119 – 4284
2025
Q2
$119 Hold
201
– – ﹤0.01% 3481
2025
Q1
$176 Buy
201
+194
+2,771% +$269 ﹤0.01% 3264
2024
Q4
$12 Buy
+7
New +$13 ﹤0.01% 3909

Other funds holding PROK

SBI Securities's PROK Position: Q3 2026 in Review

SBI Securities increased its ProKidney (PROK) stake by 2% in Q3 2026, buying an estimated $10 and bringing the position to 311 shares worth $516. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

SBI Securities first reported a position in PROK in Q4 2024 and has held it in 7 quarters since. The position peaked at $622 in Q2 2026. 92 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • SBI Securities held 311 shares of ProKidney worth $516 as of Q3 2026.
  • SBI Securities bought 6 ProKidney shares in Q3 2026, an estimated $10.
  • ProKidney made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3105 holding.
  • SBI Securities first reported a position in ProKidney in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's ProKidney position peaked at $622 in Q2 2026.
  • 92 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.